The Centre for Lymphoid Cancer (CLC) is located at BC Cancer – Vancouver.
Lymphoid cancers includes lymphoma, myeloma and leukemia.
The CLC is a multidisciplinary research program that develops new treatments and diagnostic tools for lymphoid cancers. Our team brings together senior clinical investigators and researchers from a wide range of specialties, including:
- Hematology
- Hematopathology
- Cytogenetics
- Molecular genetics
- Genomics
- Epidemiology
- Medical oncology
- Radiation oncology
Our mission is to improve understanding of the biological, genetic and environmental factors that cause lymphoid cancers. We study how these cancers behaviour and how treatments work so we can develop better diagnostic tools and more effective therapies.
The CLC works with research and clinical partners across British Columbia, Canada and around the world to:
Accelerate the development of new diagnostics and treatments for lymphoid cancers
Foster a leading-edge, multidisciplinary research environment with a strong focus on clinical applications
Build an internationally recognized centre for lymphoid cancer research
Support cross-disciplinary research that advances understanding of the biology of lymphoid cancers and leads to new treatments
Conduct collaborative research that improves our understanding of lymphoid cancers
Lymphoid cancers begin in lymphocytes, a type of white blood cell that helps the immune system fight infection.
Types of lymphoid cancer include:
- Non-Hodgkin lymphoma
- Hodgkin lymphoma
- Myeloma
- Lymphocytic leukemia.
The incidence of the lymphoid cancers is increasing faster than that of any other common cancer in North America.
Together, lymphoid cancers are the fourth most common cancer in both men and women. If current trends continue, they could become the third-most common.
In Canada:
-
About 1 in 30 people will develop a lymphoid cancer
-
The incidence of lymphoid cancers has doubled approximately every 20 years for more than 70 years
Lymphoid cancers are among the most common cancers affecting children and young adults, but they can occur at any age and in people of any background.
Effective treatments are available for many lymphoid cancers. These treatments can cure some patients, even when the cancer is advanced. However, treatment can be difficult to tolerate, and current therapies cure only about half of patients.
The Centre for Lymphoid Cancer at BC Cancer is an internationally recognized leader in research on the causes, diagnosis and treatment of lymphoid cancers.
For more information about lymphoid cancers, visit Types of Cancer.
